US Patent Issued to GE Precision Healthcare on June 24 for "Neuromodulation to target glucose transporter and/or incretin pathways" (New York Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,336,835, issued on June 24, was assigned to GE Precision Healthcare LLC (Wauwatosa, Wis.).

"Neuromodulation to target glucose transporter and/or incretin pathways" was invented by Victoria Eugenia Cotero (Troy, N.Y.), Christopher Michael Puleo (Niskayuna, N.Y.) and John Frederick Graf (Ballston Lake, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The subject matter of the present disclosure generally relates to techniques for neuromodulation that include applying energy (e.g., ultrasound energy) into the tissue to cause a change in a glucose transporter pathway molecule and/or an incretin pathway molecule. In one embodiment, the neuromodulation is ...